Physician

Joseph Lydon, M.D.

According to 2025 Medicare claims, Joseph Lydon, M.D. (NPI: 1598766859) practices addiction medicine in the Cleveland, OH market, with the plurality of this provider's patient population coming from Ashtabula, OH. This provider's primary affiliated billing organization is GMA CONSULTANTS INC (NPI: 1285829135; TIN: 341651521) and primary practice location at 44084-9352.

Lydon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 13 traditional Medicare patients, billed 22 HCPCS/CPT codes, and received $1,547 in Medicare payments. Part D data shows 407 prescription claims across 70 beneficiaries totaling $124,321 in drug costs, led by Suboxone (Buprenorphine Hcl/Naloxone Hcl). Open Payments data shows 3 records totaling $50. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $5,417 to $1,547. In contrast, Part D prescription costs have risen steadily, from $3,658 to $124,321. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$16K$32K2016 Medicare payment: $5,417 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $20,602 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $24,450 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $31,879 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $28,612 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $12,581 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,229 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,516 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,547 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201650126$5,417
201785346$20,602
201863390$24,450
201989517$31,879
202052516$28,612
202111169$12,581
20221381$5,229
20231946$3,516
20241322$1,547

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$62K$124K2015 Drug cost: $3,658 (USD; Tot_Drug_Cst)2016 Drug cost: $11,434 (USD; Tot_Drug_Cst)2017 Drug cost: $11,053 (USD; Tot_Drug_Cst)2018 Drug cost: $29,850 (USD; Tot_Drug_Cst)2019 Drug cost: $46,990 (USD; Tot_Drug_Cst)2020 Drug cost: $89,252 (USD; Tot_Drug_Cst)2021 Drug cost: $86,435 (USD; Tot_Drug_Cst)2022 Drug cost: $89,690 (USD; Tot_Drug_Cst)2023 Drug cost: $96,293 (USD; Tot_Drug_Cst)2024 Drug cost: $124,321 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151137$3,658
201665242$11,434
20172474$11,053
201820139$29,850
201934178$46,990
202040299$89,252
202131330$86,435
202251387$89,690
202345324$96,293
202470407$124,321

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
SuboxoneBuprenorphine Hcl/Naloxone Hcl641,798$36,514
SublocadeBuprenorphine14392$29,426
VivitrolNaltrexone Microspheres16450$27,424
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl781,960$9,663
LinzessLinaclotide11330$6,585

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$50Indivior Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joseph Lydon, M.D.?

Tedicare shows public-source Medicare data for Joseph Lydon, M.D. (NPI 1598766859), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph Lydon, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joseph Lydon, M.D.?

Joseph Lydon, M.D. is linked to GMA CONSULTANTS INC (billing NPI 1285829135) in the available physician profile data.

Does Joseph Lydon, M.D. have Open Payments data?

Joseph Lydon, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.